Secondary |
Product Used For Unknown Indication |
28.3% |
Schizophrenia |
14.5% |
Prophylaxis |
12.7% |
Drug Use For Unknown Indication |
10.2% |
Foetal Exposure During Pregnancy |
8.1% |
Schizoaffective Disorder |
7.1% |
Psychotic Disorder |
5.3% |
Schizophrenia, Paranoid Type |
3.9% |
Depression |
2.1% |
Anxiety |
1.4% |
Bipolar Disorder |
1.1% |
Disseminated Tuberculosis |
1.1% |
Circulatory Collapse |
0.7% |
Insomnia |
0.7% |
Respiratory Failure |
0.7% |
Respiratory Rate Decreased |
0.7% |
Antidepressant Therapy |
0.4% |
Drug Abuse |
0.4% |
Hypertension |
0.4% |
Immunosuppression |
0.4% |
|
Hypovolaemia |
10.5% |
Suicide Attempt |
10.5% |
Pulmonary Embolism |
7.9% |
Delusion |
5.3% |
Gestational Diabetes |
5.3% |
Hyponatraemia |
5.3% |
Mononeuropathy Multiplex |
5.3% |
Parkinsonism |
5.3% |
Psychotic Disorder |
5.3% |
Somnolence |
5.3% |
Tremor |
5.3% |
Weight Increased |
5.3% |
White Blood Cell Count Increased |
5.3% |
Back Pain |
2.6% |
Cardiac Failure |
2.6% |
Chronic Obstructive Pulmonary Disease |
2.6% |
Coagulation Test Abnormal |
2.6% |
Coma |
2.6% |
Completed Suicide |
2.6% |
Convulsion |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
36.8% |
Schizophrenia |
21.0% |
Depression |
5.9% |
Drug Use For Unknown Indication |
5.0% |
Agitation |
3.4% |
Anxiety Disorder |
2.9% |
Atrial Fibrillation |
2.9% |
Schizophrenia, Paranoid Type |
2.9% |
Schizoaffective Disorder |
2.7% |
Psychotic Disorder |
2.3% |
Anxiety |
2.0% |
Multiple Sclerosis |
2.0% |
Hypertension |
1.6% |
Smoking Cessation Therapy |
1.6% |
Schizophrenia, Disorganised Type |
1.4% |
Sleep Disorder |
1.4% |
Cardiac Flutter |
1.1% |
Insomnia |
1.1% |
Pain |
1.1% |
Affective Disorder |
0.9% |
|
Weight Increased |
11.7% |
Hypertension |
7.4% |
White Blood Cell Count Increased |
7.4% |
Electrocardiogram Abnormal |
6.4% |
Intentional Overdose |
6.4% |
Petechiae |
6.4% |
Neuroleptic Malignant Syndrome |
5.3% |
Abortion Spontaneous |
4.3% |
Death |
4.3% |
Drug Ineffective |
4.3% |
Mood Altered |
4.3% |
Urinary Retention |
4.3% |
Visual Acuity Reduced |
4.3% |
Vomiting |
4.3% |
Cardiac Disorder |
3.2% |
Sleep Disorder |
3.2% |
Tetany |
3.2% |
Troponin T Increased |
3.2% |
Type 1 Diabetes Mellitus |
3.2% |
White Blood Cell Count Decreased |
3.2% |
|